2023

2023319

Media News article about the initiation of a clinical trial of Heartseed was published in Nature Medicine.

2023314

PR Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences.

2023216

Congress Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at this year's Next Generation Cardiovascular Drug Development in April 25-27.

2023216

Congress Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at this year's iPSC Manufacturing Summit in May 2-4.

2023210

PR Heartseed and Novo Nordisk announce first patient dosed in clinical study with HS-001 - a cell therapy designed to restore heart function in people with advanced heart failure

1